Item 5. Other Information
Item 5. Other information
Rule 10b5-1 trading plans
During the three months ended June 30, 2026, none of our directors and executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
37
Table of Contents
Item 6. Exhibits
Exhibit
Number Exhibit Title
10.1 Lifecore Biomedical, Inc. Incentive 2026 Stock Incentive Plan , incorporated by reference to Exhibit 10.1 to the Registrant ’ s Current Report on Form 8-K filed on June 5, 2026.
31.1+ Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2+ Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1+** Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2+** Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS+ Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document
101.SCH+ Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
104+ Cover Page Interactive Data File (embedded within the Inline XBRL document)
+ Filed herewith.
** Information is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
38
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
LIFECORE BIOMEDICAL, INC.
By: /s/ Paul Josephs
Paul Josephs
President and Chief Executive Officer
(Principal Executive Officer)
By: /s/ Ryan D. Lake
Ryan D. Lake
Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: August 5, 2026
39
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.